Search clinical trials for: Prognostic Biomarker

Total 10720 results

National Cancer Institute (NCI)

Completed

Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia

Juvenile Myelomonocytic Leukemia

United States
Milton S. Hershey Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Asthma Clinical Research Network (ACRN) Trial - Best Adjustment Strategy for Asthma in Long Term (BASALT) (BASALT)

Asthma

United States
Duke University
Ortho-McNeil Neurologics, Inc.

Terminated

Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients

Alzheimer's Disease

United States
Kaohsiung Medical University Chung-Ho Memorial...
Academia Sinica, Taiwan

Unknown

Biomarkers for the Early Diagnosis, Prediction, Prognosis for Colorectal Cancers

Colorectal Cancers

Taiwan
Southwest Oncology Group
National Cancer Institute (NCI)

Withdrawn

S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307

Breast Cancer

United States
Corporacion Parc Tauli

Unknown

Acute Diverticulitis and C-Reactive Protein as a Prognostic Marker

Acute Diverticulitis

Spain
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Withdrawn

Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer

Liver Cancer
National Cancer Institute (NCI)

Terminated

Tanespimycin in Treating Patients With Stage III-IV Melanoma

Recurrent Melanoma | Stage IV Melanoma | Stage III Melanoma

United States
National Cancer Institute (NCI)

Completed

Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors

Recurrent Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Stage III Renal Cell Cancer | Recurrent Melanoma | Male Breast Cancer | Stage IV Breast Cancer | Stage IV Melanoma | Stage IV Ovarian Epithelial Cancer | Stage IIIB Breast Cancer | Stage IV Renal Cell Cancer | Recurrent Renal Cell... and other conditions

United States
Gruppo Italiano Studio Linfomi

Unknown

Prospective Collection of Biological Data of Prognostic Relevance in Patients With B-Cell Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia Stage A(0) | Chronic Lymphocytic Leukemia Stage A(I) | Chronic Lymphocytic Leukemia Stage A(II)

Italy
Samsung Medical Center

Completed

Prognostic Factor Analysis in Metastatic Esophageal Squamous Cell Carcinoma

Metastatic Esophageal Squamous Cell Carcinoma
National Cancer Institute (NCI)

Terminated

Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neuroblastoma

Recurrent Neuroblastoma | Disseminated Neuroblastoma

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors

Breast Cancer | Colorectal Cancer | Pancreatic Cancer

United States, United Kingdom
University of Ulm
University Hospital Ulm

Completed

Immune Patterns in Pain Patients DSM-IV (IPPPDIV)

Depression | Fibromyalgia | Somatoform Disorders | Chronic Fatigue Syndrome | Myofascial Pain Syndrome, Diffuse

Germany
Wythenshawe Hospital

Completed

Weight Control Programs in Women Who Have Undergone Surgery for Early Stage Breast Cancer

Breast Cancer | Weight Changes

United Kingdom
Integrated Medical Research LLC
New York State Department of Health; Alere San Diego

Completed

Improving the Management of Acute Coronary Syndromes in the Emergency Department (RACE)

Acute Coronary Syndrome

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Terminated

Role of Biomarkers in Muscle Pain and Joint Pain in Patients With Solid Tumors Receiving Paclitaxel

Pain | Arthralgia | Unspecified Adult Solid Tumor, Protocol Specific

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

Immunoreactivity to Cetuximab in Cancer Patients

Head and Neck Cancer | Colorectal Cancer
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Terminated

Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy

Head and Neck Cancer

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx

Head and Neck Cancer
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer

Head and Neck Cancer
Corporacion Parc Tauli

Unknown

Analysis of a New Biomarker for Prostate Cancer Diagnosis (HEM)

Patients With Suspected Prostate Cancer

Spain
National Cancer Institute (NCI)

Completed

GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific | Stage IIIC Rectal Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal Cancer

United States
National Cancer Institute (NCI)

Completed

Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic... and other conditions

United States
National Cancer Institute (NCI)

Completed

Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer

Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Recurrent Renal Cell Cancer

United States
National Cancer Institute (NCI)

Completed

Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer

Stage IV Ovarian Epithelial Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Stage IV Primary Peritoneal Cavity Cancer

United States
National Taiwan University Hospital

Completed

Identification and Characterization of the Biomarker in Synovial Fluid for Hyaluronic Acid Therapy in Osteoarthritis

Osteoarthritis

Taiwan
Duke University
Novartis Pharmaceuticals

Completed

Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)

Glioblastoma | Gliosarcoma

United States
Royal Marsden NHS Foundation Trust
AstraZeneca

Unknown

Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours (FGFR)

Breast Cancer | Gastric Cancer | Squamous Cell Carcinoma of the Lung | Oesophageal Cancer

United Kingdom
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Terminated

Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan

Mucositis | Multiple Myeloma and Plasma Cell Neoplasm

United States
CF Therapeutics Development Network Coordinating...
Cystic Fibrosis Foundation

Completed

Detection of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity in Rectal Tissues From Human Subjects

Cystic Fibrosis

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery

Colorectal Cancer

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

Biomarkers in Predicting Response to Treatment in Patients Who Have Undergone Surgery for Pancreatic Cancer

Pancreatic Cancer

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Terminated

Celecoxib in Treating Patients With Early-Stage Rectal Cancer

Colorectal Cancer

United States
Chinese PLA General Hospital

Unknown

The Prognostic Assessment of Extubation in Aged Patients With Multiple Organ Dysfunction Syndrome

Multiple Organ Dysfunction Syndrome

China
BioIncept LLC
Merck KGaA, Darmstadt, Germany

Unknown

Prognostic Value of PIF Detection in Embryo Culture Media Correlation With Pregnancy Outcome (PIF-SET1)

Pregnancy | Fertility

United States, France, Greece
National Cancer Institute (NCI)

Terminated

Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer

Recurrent Salivary Gland Cancer | Stage IVA Salivary Gland Cancer | Stage IVB Salivary Gland Cancer | Stage IVC Salivary Gland Cancer | High-grade Salivary Gland Mucoepidermoid Carcinoma | Salivary Gland Acinic Cell Tumor | Salivary Gland Adenocarcinoma | Salivary Gland Poorly Differentiated Carcinoma

United States
National Cancer Institute (NCI)

Completed

S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Tongue Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous... and other conditions

United States
National Cancer Institute (NCI)

Completed

Cilengitide in Treating Patients With Metastatic Prostate Cancer

Recurrent Prostate Cancer | Stage IV Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer

Recurrent Neuroendocrine Carcinoma of the Skin | Stage III Neuroendocrine Carcinoma of the Skin | Stage II Neuroendocrine Carcinoma of the Skin

United States
National Cancer Institute (NCI)

Completed

Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer

Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Recurrent Renal Cell Cancer

United States
National Cancer Institute (NCI)

Completed

S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer

Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Large Cell Lung Cancer

United States
National Cancer Institute (NCI)

Completed

Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer

Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Recurrent Renal Cell Cancer

United States
Johannes Gutenberg University Mainz
UCB Pharma GmbH

Completed

Study on the Treatment of Elderly Patients With Older and Newer Antiepileptic Drugs (STEP-ONE)

Focal Epilepsy

Germany
National Cancer Institute (NCI)

Completed

Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans

Recurrent Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Dermatofibrosarcoma Protuberans | Adult Fibrosarcoma

United States
National Cancer Institute (NCI)

Completed

Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Bronchoalveolar Cell Lung Cancer

United States
National Cancer Institute (NCI)

Completed

CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Extensive Stage Small Cell Lung Cancer

United States
National Cancer Institute (NCI)

Completed

A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer

Recurrent Non-small Cell Lung Cancer

United States
National Cancer Institute (NCI)

Completed

Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States
National Cancer Institute (NCI)

Completed

Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck

Tongue Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous... and other conditions

United States

Search clinical trials for: Prognostic Biomarker

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations